NGEN
NervGen Pharma Corp.
1.80$
+1.7%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +5.8% | -0.7% | -60.9% | -2.6% | +8.0% | -12.2% | +1.1% | -0.3% | +85.0% | -45.1% | +1.0% | – | |
| – | – | – | – | – | – | -12.6% | +38.1% | -44.9% | +385.0% | -82.4% | +187.4% | – | |
| – | +397.2% | -40.3% | +137.1% | -219.0% | – | -52.4% | +125.6% | -137.5% | – | -4,538.0% | – | – | |
| – | -100.0% | – | – | – | – | – | – | – | – | – | -100.0% | – | |
| – | – | – | – | +199.7% | +0.1% | -0.5% | +1.1% | -0.3% | +85.0% | -81.7% | -100.9% | – | |
| – | – | – | – | – | – | +0.0% | 0.0% | +0.0% | 0.0% | -66.7% | -100.0% | – | |
| – | +3.6% | +29,378.4% | -99.5% | +142.2% | +15.0% | +309.0% | +276.9% | -79.1% | +1,773.7% | -84.9% | +2,737.6% | – | |
| – | – | – | -122.0% | – | – | – | – | -334.5% | – | -142.5% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.